Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Kyle J Gaulton, Teresa Ferreira, Yeji Lee, Anne Raimondo, Reedik Mägi, Michael E Reschen, Anubha Mahajan, Adam Locke, N William Rayner, Neil Robertson, Robert A Scott, Inga Prokopenko, Laura J Scott, Todd Green, Thomas Sparso, Dorothee Thuillier, Loic Yengo, Harald Grallert, Simone WahlMattias Frånberg, Rona J Strawbridge, Hans Kestler, Himanshu Chheda, Lewin Eisele, Stefan Gustafsson, Valgerdur Steinthorsdottir, Gudmar Thorleifsson, Lu Qi, Lennart C Karssen, Elisabeth M van Leeuwen, Sara M Willems, Man Li, Han Chen, Christian Fuchsberger, Phoenix Kwan, Clement Ma, Michael Linderman, Yingchang Lu, Soren K Thomsen, Jana K Rundle, Nicola L Beer, Martijn van de Bunt, Anil Chalisey, Hyun Min Kang, Benjamin F Voight, Gonçalo R Abecasis, Peter Almgren, Damiano Baldassarre, Beverley Balkau, Andrew D Morris

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology